3WV-37871-35202

3 vaccinations 12 coded responses 23 check-ins 12 free-text entries 12 call cases

Sex: Female
Age at first dose: 51-55
ZIP prefix: 069 / CT
Registered: 2020-12-19

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Possible VAERS report

VAERS ID	Confidence	Score	Runner-up	Shared symptoms	Dose	State	VAERS vaccinated / onset / received	Call case
1758796 (opens in a new window)	high	11 / 11	6	5 of 10 VAERS symptoms	same dose (3)	CT matches	2021-08-27 / 2021-08-28 / 2021-10-04 received the same day as the last call	case 1042644

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-18
Dose 1 — Pfizer-BioNTech
2020-12-19
Registered in v-safe
2020-12-19
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2020-12-19
Report sent to call center — days 1–6 daily, dose 1
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2020-12-20
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2020-12-20
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2020-12-21
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Fatigue or tiredness

Adult check-in
2020-12-22
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-23
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-24
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Itching · None

Adult check-in
2020-12-25
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-01
Health check-in — day 14, dose 1
Feeling: Fair

Adult check-in
2021-01-08
Survey response — day 21, dose 1
MedDRA: Arthritis, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities

Free text: My arthritis is acting up

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-08
Report sent to call center — day 21, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-01-12
Dose 2 — Pfizer-BioNTech
2021-01-13
Survey response — days 1–6 daily, dose 2
MedDRA: Confusional state — Feeling: Poor · Site: Pain, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities

Free text: Confusion

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-13
Report sent to call center — days 1–6 daily, dose 2
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-01-14
Survey response — days 1–6 daily, dose 2
MedDRA: Condition aggravated, Ocular myasthenia, Pre-existing disease — Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Ocular myasthenia graves flare

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-14
Report sent to call center — days 1–6 daily, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-01-15
Survey response — days 1–6 daily, dose 2
MedDRA: Eyelid ptosis, Muscular weakness — Feeling: Poor · Site: Pain, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities

Free text: Ptosis bilaterally from myasthenia

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-15
Report sent to call center — days 1–6 daily, dose 2
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-01-16
Survey response — days 1–6 daily, dose 2
MedDRA: Eyelid ptosis — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Free text: Ptosis bilaterally improving.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-16
Report sent to call center — days 1–6 daily, dose 2
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-01-17
Survey response — days 1–6 daily, dose 2
MedDRA: Eyelid ptosis — Feeling: Fair · Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities

Free text: Ptosis bilaterally

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-17
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-01-20
Health check-in — day 7, dose 2
Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-01-26
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-09
Survey response — day 28, dose 2
MedDRA: Autoimmune disorder, Eyelid ptosis, Muscular weakness — Feeling: Fair · Be unable to do your normal daily activities

Free text: Worsening autoimmune symptoms ptosis. Muscle weakness.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-16
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-02-25
Survey response — day 42, dose 2
MedDRA: Abdominal pain, Anti-thyroid antibody positive, Antibody test positive, Antinuclear antibody increased, Coeliac disease — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Abdominal pain, diagnosed with celiac disease. Developed antibodies to celiac and thyroid. Increased ANA.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-25
Report sent to call center — day 42, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-03-04
Call successful
Completed over the phone
2021-07-15
Survey response — 6 months, dose 2
MedDRA: Asthenia, Dysphagia, Dysphonia, Sacroiliitis — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Sacroilititis, difficulty swallowing vocal changes. Increasing general weakness.

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-07-15
Report sent to call center — 6 months, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-07-21
Call 1 — Left Voicemail
2021-08-27
Dose 3 — Pfizer-BioNTech
2021-09-29
Survey response — day 28, dose 3
MedDRA: Dysphagia, Low density lipoprotein abnormal, Myasthenia gravis, Oesophageal motility disorder, Oesophageal obstruction, Swallow study abnormal, Unevaluable event — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Symptoms: I was diagnosed with generalized myasthenia gravis LRP4 + and have not been able to swallow. Esophagus Manometry showed lower esophagus obstruction and a motility disorder. · Healthcare visit (other): Tests

MedDRA releases: 2024-11 · check-in free text available
2021-09-29
Report sent to call center — day 28, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2021-10-03
Survey response — day 35, dose 3
MedDRA: Asthenia, Condition aggravated, Diplopia, Dysphagia, Headache, Insomnia, Posture abnormal, Pre-existing disease — Feeling: Poor · Be unable to do your normal daily activities

Free text: weakness, trouble swallowing, headaches, double vision, trouble hold head up (flare of myasthenia symptoms mostly), difficulty sleeping

MedDRA releases: 2024-11 · check-in free text available
2021-10-04
Call successful
Completed over the phone
2021-11-26
Survey response — 3 months, dose 3
MedDRA: Abdominal pain upper, Liver function test increased, Magnetic resonance imaging abnormal, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Symptoms: RUQ pain, Increased LFTs, hepatocellular inflammation on MRI MRCP and dilated biliary ducts AND CBD · Healthcare visit (other): Radiology, labs

MedDRA releases: 2024-11 · check-in free text available
2021-11-26
Report sent to call center — 3 months, dose 3
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2021-11-29
Call successful
Reported to VAERS during previous contact from GDIT

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-18	Pfizer-BioNTech
2	2021-01-12	Pfizer-BioNTech
3	2021-08-27	Pfizer-BioNTech	No

Call center

12 call center cases

12 successful

VAERS report filed, before or during a call: 9

See the call center timeline

Free text

Release 1 — day 21, dose 1

2021-01-08

Symptoms: My arthritis is acting up

Release 1 — days 1–6 daily, dose 2

2021-01-13

Systemic reaction (other): Confusion

Release 2 — days 1–6 daily, dose 2

2021-01-14

Systemic reaction (other): Ocular myasthenia graves flare

2021-01-15

Systemic reaction (other): Ptosis bilaterally from myasthenia

2021-01-16

Systemic reaction (other): Ptosis bilaterally improving.

2021-01-17

Systemic reaction (other): Ptosis bilaterally

Release 3 — day 28, dose 2

2021-02-09

Symptoms: Worsening autoimmune symptoms ptosis. Muscle weakness.

Release 4 — day 42, dose 2

2021-02-25

Symptoms: Abdominal pain, diagnosed with celiac disease. Developed antibodies to celiac and thyroid. Increased ANA.

Release 9 — 6 months, dose 2

2021-07-15

Symptoms: Sacroilititis, difficulty swallowing vocal changes. Increasing general weakness.

Release 9 — day 28, dose 3

2021-09-29

Symptoms: I was diagnosed with generalized myasthenia gravis LRP4 + and have not been able to swallow. Esophagus Manometry showed lower esophagus obstruction and a motility disorder.

Healthcare visit (other): Tests

Release 9 — day 35, dose 3

2021-10-03

Symptoms: weakness, trouble swallowing, headaches, double vision, trouble hold head up (flare of myasthenia symptoms mostly), difficulty sleeping

Release 10 — 3 months, dose 3

2021-11-26

Symptoms: RUQ pain, Increased LFTs, hepatocellular inflammation on MRI MRCP and dilated biliary ducts AND CBD

Healthcare visit (other): Radiology, labs

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Unevaluable event	·	·	✓
SD	Abdominal pain	✓	✓	✓
SD	Abdominal pain upper	·	·	✓
SD	Anti-thyroid antibody positive	✓	✓	✓
SD	Antibody test positive	✓	✓	✓
SD	Antinuclear antibody increased	✓	✓	✓
SD	Arthritis	✓	✓	✓
SD	Asthenia	✓	·	✓
SD	Autoimmune disorder	✓	✓	✓
SD	Coeliac disease	✓	✓	✓
SD	Condition aggravated	·	·	✓
SD	Diplopia	·	·	✓
SD	Dysphagia	✓	·	✓
SD	Dysphonia	✓	·	✓
SD	Eyelid ptosis	✓	✓	✓
SD	Headache	·	·	✓
SD	Insomnia	·	·	✓
SD	Liver function test increased	·	·	✓
SD	Low density lipoprotein abnormal	·	·	✓
SD	Magnetic resonance imaging abnormal	·	·	✓
SD	Muscular weakness	✓	✓	✓
SD	Myasthenia gravis	·	·	✓
SD	Oesophageal motility disorder	·	·	✓
SD	Oesophageal obstruction	·	·	✓
SD	Posture abnormal	·	·	✓
SD	Pre-existing disease	✓	✓	✓
SD	Sacroiliitis	✓	·	✓
SD	Swallow study abnormal	·	·	✓
SD	Unevaluable event	·	·	✓
SRO	Condition aggravated	✓	✓	✓
SRO	Confusional state	✓	✓	✓
SRO	Eyelid ptosis	✓	✓	✓
SRO	Muscular weakness	✓	✓	✓
SRO	Ocular myasthenia	○	✓	○
SRO	Pre-existing disease	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release